Rate of Kidney Function Decline is Associated With Kidney and Heart Failure in Individuals With Type 1 Diabetes

被引:0
|
作者
Sandholm, Niina [1 ,2 ,3 ,4 ]
Valo, Erkka [1 ,2 ,3 ,4 ]
Tuomilehto, Jaakko [5 ,6 ,7 ,8 ]
Harjutsalo, Valma [1 ,2 ,3 ,4 ]
Groop, Per-Henrik [1 ,2 ,3 ,4 ,9 ,10 ,11 ]
机构
[1] Folkhalsan Res Ctr, Helsinki, Finland
[2] Univ Helsinki, Dept Nephrol, Helsinki, Finland
[3] Helsinki Univ Hosp, Helsinki, Finland
[4] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland
[5] Finnish Inst Hlth & Welf, Populat Hlth Unit, Helsinki, Finland
[6] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[7] King Abdulaziz Univ, Saudi Diabet Res Grp, Jeddah, Saudi Arabia
[8] Inst Salud Carlos III, Natl Sch Publ Hlth, Dept Int Hlth, Madrid, Spain
[9] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia
[10] Univ Helsinki, Folkhalsan Res Ctr, Dept Nephrol, Haartmaninkatu 8, Helsinki 00290, Finland
[11] Helsinki Univ Hosp, Biomedicum 1, Haartmaninkatu 8, Helsinki 00290, Finland
来源
KIDNEY INTERNATIONAL REPORTS | 2023年 / 8卷 / 10期
基金
芬兰科学院;
关键词
competing risk regression; decline of eGFR; eGFR slope; heart failure; kidney failure; type; 1; diabetes; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; RAPID EGFR DECLINE; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; PAST DECLINE; FOLLOW-UP; MORTALITY; RISK; GFR;
D O I
10.1016/j.ekir.2023.07.026
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Diabetes is the most common cause of chronic kidney disease (CKD). Urinary albumin excretion rate (AER) and estimated glomerular filtration rate (eGFR) are commonly used to monitor the onset and progression of diabetic kidney disease (DKD). We studied if the preceding rate of kidney function decline, that is, the eGFR slope, is independently associated with incident clinical cardiorenal events. Methods: This study included longitudinal data for 2498 Finnish individuals with type 1 diabetes (T1D). The eGFR slope was calculated from 5 years preceding the study visit. Data on kidney failure, coronary heart disease (CHD), stroke, 3-point major adverse cardiovascular events (MACE), heart failure, and death were obtained from national registries. The associations between the eGFR slope and incident events were assessed with multivariable competing risk models during the average follow-up of 9.2 years. Results: The eGFR slopes were associated (P <= 0.001) with all outcomes when adjusted for age, sex, and HbA1c. However, eGFR slope remained associated only with the composite outcome of kidney failure or death when the albuminuria group and eGFR at the study visit were included in the model (P = 0.041). In addition, eGFR slope was independently associated with kidney failure in individuals without CKD (eGFR > 60 ml/min per 1.73 m(2); P = 0.044), and with heart failure in those with CKD (P = 0.033). However, eGFR slope did not markedly improve the model C-index. Conclusion: The eGFR slope was independently associated with kidney failure in those without CKD, and with heart failure in those with CKD. However, it is unlikely to have major relevance for clinical practice when the current eGFR and albuminuria status are known.
引用
收藏
页码:2043 / 2055
页数:13
相关论文
共 50 条
  • [1] Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort Rapid kidney function decline and heart failure in T2D
    Bueno Junior, Carlos Roberto
    Bano, Arjola
    Tang, Yaling
    Sun, Xiuqin
    Abate, Alex
    Hall, Elizabeth
    Mitri, Joanna
    Morieri, Mario Luca
    Shah, Hetal
    Doria, Alessandro
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular disease
    Sharma, Abhinav
    Inzucchi, Silvio E.
    Testani, Jeffrey M.
    Ofstad, Anne Pernille
    Fitchett, David
    Mattheus, Michaela
    Verma, Subodh
    Zannad, Faiez
    Wanner, Christoph
    Kraus, Bettina J.
    ESC HEART FAILURE, 2024, 11 (02): : 737 - 747
  • [3] Prognosis for Type 1 Diabetes with Diabetic Nephropathy between 2000 and 2020- Changes in Kidney Function Decline Over Time and Development of Cardiovascular Disease, Kidney Failure, and Mortality
    Poulsen, Christina G.
    Jesse, Kristin
    Carstensen, Bendix
    Hansen, Tine W.
    Persson, Frederik
    Vistisen, Dorte
    Rossing, Peter
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (12): : 3403 - 3413
  • [4] Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohortRapid kidney function decline and heart failure in T2D
    Carlos Roberto Bueno Junior
    Arjola Bano
    Yaling Tang
    Xiuqin Sun
    Alex Abate
    Elizabeth Hall
    Joanna Mitri
    Mario Luca Morieri
    Hetal Shah
    Alessandro Doria
    Cardiovascular Diabetology, 22
  • [5] Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes
    Jiang, Guozhi
    Luk, Andrea On Yan
    Tam, Claudia Ha Ting
    Xie, Fangying
    Carstensen, Bendix
    Lau, Eric Siu Him
    Lim, Cadmon King Poo
    Lee, Heung Man
    Ng, Alex Chi Wai
    Ng, Maggie Chor Yin
    Ozaki, Risa
    Kong, Alice Pik Shan
    Chow, Chun Chung
    Yang, Xilin
    Lan, Hui-yao
    Tsui, Stephen Kwok Wing
    Fan, Xiaodan
    Szeto, Cheuk Chun
    So, Wing Yee
    Chan, Juliana Chung Ngor
    Ma, Ronald Ching Wan
    KIDNEY INTERNATIONAL, 2019, 95 (01) : 178 - 187
  • [6] Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus
    Keum, Youngshin
    Caramori, Maria Luiza
    Cherney, David Z.
    Crandall, Jill P.
    de Boer, Ian H.
    Lingvay, Ildiko
    Mcgill, Janet B.
    Polsky, Sarit
    Pop-Busui, Rodica
    Rossing, Peter
    Sigal, Ronald J.
    Mauer, Michael
    Doria, Alessandro
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (01): : 62 - 71
  • [7] Association of plasma ceramide with decline in kidney function in patients with type 2 diabetes
    Gurung, Resham L.
    Yiamunaa, M.
    Tham, Wai Kin
    Liu, Sylvia
    Zheng, Huili
    Lee, Janus
    Ang, Keven
    Wenk, Markus
    Subramaniam, Tavintharan
    Sum, Chee Fang
    Torta, Federico
    Liu, Jian-Jun
    Lim, Su Chi
    JOURNAL OF LIPID RESEARCH, 2024, 65 (06)
  • [8] Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study
    Kaewput, Wisit
    Thongprayoon, Charat
    Chewcharat, Api
    Rangsin, Ram
    Satirapoj, Bancha
    Kaewput, Chalermrat
    Suwannahitatorn, Picha
    Bathini, Tarun
    Mao, Michael A.
    Cato, Liam D.
    Harrison, Andrew M.
    Vaitla, Pradeep
    Cheungpasitporn, Wisit
    THERAPEUTIC APHERESIS AND DIALYSIS, 2020, 24 (06) : 677 - 687
  • [9] Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Lambelet, Marc
    Lawatscheck, Robert
    Bakris, George L.
    Ruilope, Luis M.
    Agarwal, Rajiv
    JACC-HEART FAILURE, 2022, 10 (11) : 860 - 870
  • [10] Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes
    Harma, Mari-Anne
    Dahlstrom, Emma H.
    Sandholm, Niina
    Forsblom, Carol
    Groop, Per-Henrik
    Lehto, Markku
    DIABETOLOGIA, 2020, 63 (07) : 1349 - 1354